Cancer Immunotherapy and Immunomonitoring - Call for Papers

["Steele, Deborah" <deborah.steele@usask.ca>]

 

 

If you cannot view this page, please click here: http://gtcbio.com/newsletter/CancerImmunoI-w.htm

	Dear Colleague, The field of Cancer Immunotherapy and Immunomonitoring (CITIM) is of continuously escalating significance, as well as scientifically, economically and socially important. The CITIM Conference on May 18-21, 2009 in Kiev, Ukraine allows scientists, clinicians, medical practitioners and specialists, students, R&D experts and patients to meet together and discuss the latest therapeutic, preventive and diagnostic developments in the field. Register now to save up to up $300! *Refer a Friend and win a cash prize! If you refer this conference to a colleague and he/she registers, you will receive a $50 check! Send an email to infogtcbio@gtcbio.com with the name and contact information of the person you are referring and you win!	HIGHLIGHTS - 25% of Accepted Abstracts will be chosen for Oral Presentations! - Multiple Tracks and Workshops - Intimate Interaction with Key Opinion Leaders - Private tours in beautiful Kiev!   UPCOMING EVENTS Biomarker Discovery Europe Oct. 2-3, 2008 Dublin, Ireland 4th Neurodegenerative Diseases Drug Discovery Oct. 9-10, 2008 Philadelphia, PA 4th Modern Drug Discovery and Development Summit 6 Full Tracks 3 Short Symposia 6 Study Sessions Oct. 15-17, 2008 San Diego, CA Advances in Stem Cell Discoveries Oct. 27-28, 2008 San Francisco, CA 10% discount by Sept 27 4th Metabolic Diseases World Summit Nov. 6-7, 2008 Boston, MA 10% discount by Oct. 6 6th Vaccines: All Things Considered Nov. 13-14, 2008 Washington, DC 10% discount by Oct 13 CNS Diseases Partnering & Deal-Making Summit Dec. 1-2, 2008 Boston, MA 20% discount by Oct 1
	Program Developments
	Session I: Regulatory and Effector Mechanisms in Cancer Session II: Tumor Microenvironment: Immunological Perception Session III: Cancer Immunotherapy: Problems and Perspectives Session IV: Cancer Immunotherapy: New Approaches Session V: Cancer Biomarkers: Diagnosis, Prognosis or Targets for Therapy? Session VI: Immunomonitoring in Cancer Clinical Trials Click here to view a FULL AGENDA Distinguished Presenters: Natalia Aptsiauri, University of Granada Ron Apte, University of Beer Sheva Anatoly Baryshnikov, Cancer Research Center Gurkamal Chatta, University of Pittsburgh Cancer Institute Sophie Dessureault, University of South Florida Federico Garrido, Hospital Universitario Virgen de las Nieves Larisa Geskin, University of Pittsburgh Medical Center Gunter Haemmerling, German Cancer Research Center Arthur A. Hurwitz, NIH Zaira G. Kadagidze, Cancer Research Center Alexey Karulin, Cellular Technology Ltd. Adriana T. Larregina, University of Pittsburgh Franco Marincola, NIH, NCI Anatoli Malyguine, SAIC-Frederick, Inc. NIH, NCI John C. Morris, NIH, NCI Bijay Mukherji, University of Connecticut Sergei A. Nedospasov, Institute for Molecular Biology Joost J. Oppenheim, NIH, NCI Michail Papamichail, Cancer Immunology and Immunotherapy Center Tomas Sayers, NIH, NCI Valentin P. Shichkin, Ukraine State University Michael R. Shurin, University of Pittsburgh Claude Sportès, NIH Joseph A. Trapani, Peter MacCallum Cancer Centre Viktor Umansky, German Cancer Research Center Elena Voronov, Ben-Gurion University Simon Watkins, University of Pittsburgh Theresa Whiteside, University of Pittsburgh Cancer Institute Eitan Yefenof, Hebrew University [Speaker List] SEND YOUR TEAM...Register 2, and the 3rd person goes FREE!
	Abstract Submissions: Submit an abstract for poster presentation and have the chance to give an oral presentation. Deadline is March 15, 2009. Click here for submission.
For Business Development & Exhibiting opportunities, contact Josette Barba at 626-256-6405 x105 or via email at josette.barba@gtcbio.com
This advertisement comes to you from GTCbio, 434 W. Foothill Blvd, Monrovia, CA 91016. To update your contact information, please click here. If you prefer not to receive further messages from this sender, please send an email to remove@gtcbio.com. Please make sure to remove the forwarding email address and any email alias.